Although transvaginal mesh and surgical mesh were designed with the purpose of reinforcing dropping organs, helping patients with Pelvic Organ Prolapse (POP) and Urinary Stress Incontinence, the Food and Drug Administration (FDA) received hundreds of reports of negative side effects and complications. As a result of problems associated, the FDA issued an alert in October 2008, warning consumers and health care professionals against the risks tied to transvaginal and surgical mesh.
Erosion, infection, pain, urinary complications and reoccurrence of problems that prompted mesh placement are just some of the consequences reported to the FDA, the administration noted in their health notification.Transvaginal Mesh Complications and FDA Alerts
In contrast with placement of surgical mesh through the abdomen, transvaginal mesh is placed through vaginal insertion. By 2011, the FDA released information, citing increasingly frequent complications tied to the medical device and reported that "serious complications associated with surgical mesh for transvaginal repair of POP are not rare."
While more than 1,000 women have experienced problems related to transvaginal mesh, studies performed by the FDA and other health and safety advocates have revealed that mesh may not actually improve the "quality of life" more than other methods of treatment. Instead, other options for the treatment of POP or stress urinary incontinence may actually be just as effective with fewer risks of injury.Transvaginal Mesh & Surgical Mesh Law Firm
If you or a loved one has suffered from infection, vaginal migration, mesh shrinkage, vaginal erosion, mesh movement or other complications related to transvaginal mesh or surgical mesh placement, call our transvaginal mesh law firm for a free consultation today! Our team of experienced medical device attorneys is currently helping clients injured by defective surgical mesh, holding negligent mesh manufacturers responsible for injuries, pain and suffering resulting. We care. We can help.